Wei Song, Dan Sha, Leping Li, Binbin Gao, Xiaogang Sun, Jinshen Wang, Xu Zhou, Liang Shang, Changqing Jing, Chensheng Li, Wenmao Geng, Xiaobo Guo, Shulei Zhao, Dechao Wang, Haiyan Jing, Cong Sun, Zhaofei Pang, Liguang Wang, Ziwei Yu, Mingyi Li. "Phase II trial of transarterial chemoembolization followed by sintilimab (anti-PD-1), oxaliplatin, and S-1 combined with either trastuzumab (HER-2 positive) or apatinib (HER-2 negative) as first-line therapy for gastric cancer with liver metastases.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.4050